Clever Leaves Holdings Inc. (CLVR)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -17.89 Million USD | 77.25% |
| 2022 | -66.1 Million USD | -44.86% |
| 2021 | -45.63 Million USD | -10.18% |
| 2020 | -41.41 Million USD | 13.95% |
| 2019 | -48.13 Million USD | -753.85% |
| 2018 | 7.36 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -3.59 Million USD | 11.91% |
| 2023 Q1 | -4.08 Million USD | 85.84% |
| 2023 Q3 | -5.13 Million USD | -42.92% |
| 2023 Q4 | -2.22 Million USD | 56.73% |
| 2023 FY | -15.03 Million USD | 77.25% |
| 2022 Q4 | -28.81 Million USD | -42.92% |
| 2022 Q3 | -20.16 Million USD | -1827.63% |
| 2022 FY | -66.1 Million USD | -44.86% |
| 2022 Q2 | -1.04 Million USD | 95.7% |
| 2022 Q1 | -24.33 Million USD | -1.38% |
| 2021 FY | -45.63 Million USD | -10.18% |
| 2021 Q4 | -24 Million USD | -2512.06% |
| 2021 Q3 | 995 Thousand USD | 111.11% |
| 2021 Q2 | -8.95 Million USD | 34.94% |
| 2021 Q1 | -13.76 Million USD | -18.42% |
| 2020 Q4 | -11.62 Million USD | -128.19% |
| 2020 Q3 | -5.09 Million USD | 36.4% |
| 2020 Q2 | -8 Million USD | 13.71% |
| 2020 Q1 | -9.28 Million USD | 43.08% |
| 2020 FY | -41.41 Million USD | 13.95% |
| 2019 Q1 | -6.08 Million USD | 0.0% |
| 2019 FY | -48.13 Million USD | -753.85% |
| 2019 Q3 | -10.64 Million USD | -63.77% |
| 2019 Q4 | -16.3 Million USD | -53.25% |
| 2019 Q2 | -6.49 Million USD | -6.74% |
| 2018 FY | 7.36 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 48.15 Million USD | 137.17% |
| China SXT Pharmaceuticals, Inc. | -3.09 Million USD | -477.661% |
| Embecta Corp. | 70.4 Million USD | 125.425% |
| Pacira BioSciences, Inc. | 41.95 Million USD | 142.662% |
| PainReform Ltd. | -9.34 Million USD | -91.556% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -297.222% |
| SCYNEXIS, Inc. | 67.04 Million USD | 126.699% |
| Journey Medical Corporation | -3.85 Million USD | -364.547% |
| Safety Shot Inc | -15.08 Million USD | -18.67% |
| Alpha Teknova, Inc. | -36.78 Million USD | 51.335% |
| Bright Green Corporation | -13.12 Million USD | -36.346% |
| Procaps Group, S.A. | 42.54 Million USD | 142.076% |
| Alvotech | -551.73 Million USD | 96.756% |
| ANI Pharmaceuticals, Inc. | 18.77 Million USD | 195.314% |
| Aquestive Therapeutics, Inc. | -7.87 Million USD | -127.433% |
| Cosmos Health Inc. | -18.54 Million USD | 3.471% |
| Dynavax Technologies Corporation | -6.38 Million USD | -180.153% |
| Esperion Therapeutics, Inc. | -209.24 Million USD | 91.446% |
| Intra-Cellular Therapies, Inc. | -139.67 Million USD | 87.185% |
| Sunshine Biopharma, Inc. | -4.5 Million USD | -297.222% |
| Theratechnologies Inc. | -23.95 Million USD | 25.287% |
| Harrow Health, Inc. | -24.41 Million USD | 26.676% |
| Sonoma Pharmaceuticals, Inc. | -4.83 Million USD | -270.196% |
| Biofrontera Inc. | -20.13 Million USD | 11.087% |
| DURECT Corporation | -27.62 Million USD | 35.205% |
| Supernus Pharmaceuticals, Inc. | 1.31 Million USD | 1460.106% |
| Cronos Group Inc. | -73.96 Million USD | 75.8% |
| OptiNose, Inc. | -35.48 Million USD | 49.556% |
| Ironwood Pharmaceuticals, Inc. | -1 Billion USD | 98.214% |
| Kala Pharmaceuticals, Inc. | -42.19 Million USD | 57.584% |
| RedHill Biopharma Ltd. | 23.91 Million USD | 174.841% |
| Organogenesis Holdings Inc. | 4.94 Million USD | 461.962% |
| Guardion Health Sciences, Inc. | 158.03 Thousand USD | 11426.115% |
| Cumberland Pharmaceuticals Inc. | -6.27 Million USD | -185.047% |
| Radius Health, Inc. | -25.79 Million USD | 30.6% |
| Universe Pharmaceuticals INC | -6.16 Million USD | -190.424% |
| ProPhase Labs, Inc. | -16.78 Million USD | -6.656% |
| Phibro Animal Health Corporation | 2.41 Million USD | 840.853% |
| Procaps Group S.A. | 42.54 Million USD | 142.076% |
| TherapeuticsMD, Inc. | -10.27 Million USD | -74.149% |
| Viatris Inc. | 54.7 Million USD | 132.722% |
| Rockwell Medical, Inc. | -8.43 Million USD | -112.099% |
| Aytu BioPharma, Inc. | -15.84 Million USD | -12.97% |
| SIGA Technologies, Inc. | 68.06 Million USD | 126.295% |
| Tilray Brands, Inc. | -244.98 Million USD | 92.694% |
| Lifecore Biomedical, Inc. | 12.01 Million USD | 248.997% |
| Shineco, Inc. | -22.44 Million USD | 20.268% |
| PetIQ, Inc. | 2.13 Million USD | 939.934% |
| Regencell Bioscience Holdings Limited | -4.3 Million USD | -316.078% |
| Incannex Healthcare Limited | -18.45 Million USD | 3.034% |
| Neurocrine Biosciences, Inc. | 249.7 Million USD | 107.168% |
| Alimera Sciences, Inc. | -20.13 Million USD | 11.092% |
| Silver Spike Investment Corp. | 7.34 Million USD | 343.852% |
| Assertio Holdings, Inc. | -331.94 Million USD | 94.608% |
| Shuttle Pharmaceuticals Holdings, Inc. | -6.59 Million USD | -171.496% |
| Petros Pharmaceuticals, Inc. | -8.16 Million USD | -119.265% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 10.761% |
| Avadel Pharmaceuticals plc | -160.27 Million USD | 88.832% |
| Hempacco Co., Inc. | -13.12 Million USD | -36.362% |
| Talphera, Inc. | -18.39 Million USD | 2.707% |
| Alvotech | -551.73 Million USD | 96.756% |
| Eagle Pharmaceuticals, Inc. | 35.64 Million USD | 150.219% |
| Lantheus Holdings, Inc. | 326.66 Million USD | 105.479% |
| Currenc Group, Inc. | -15.3 Million USD | -16.937% |
| Kamada Ltd. | 8.28 Million USD | 316.067% |
| Indivior PLC | 2 Million USD | 994.95% |
| Evoke Pharma, Inc. | -7.79 Million USD | -129.701% |
| Flora Growth Corp. | -57.03 Million USD | 68.618% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 10.761% |
| Evolus, Inc. | -61.68 Million USD | 70.983% |
| HUTCHMED (China) Limited | 100.78 Million USD | 117.76% |
| Amphastar Pharmaceuticals, Inc. | 137.54 Million USD | 113.013% |
| Akanda Corp. | -32.27 Million USD | 44.542% |